Forecasting COVID-19 recovered cases with Artificial Neural Networks to enable designing an effective blood supply chain.
Artificial neural networks
Blood supply chain
CIP Therapy
COVID-19
Forecasting
Journal
Computers in biology and medicine
ISSN: 1879-0534
Titre abrégé: Comput Biol Med
Pays: United States
ID NLM: 1250250
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
03
08
2021
revised:
08
11
2021
accepted:
10
11
2021
pubmed:
19
11
2021
medline:
15
12
2021
entrez:
18
11
2021
Statut:
ppublish
Résumé
This study introduces a forecasting model to help design an effective blood supply chain mechanism for tackling the COVID-19 pandemic. In doing so, first, the number of people recovered from COVID-19 is forecasted using the Artificial Neural Networks (ANNs) to determine potential donors for convalescent (immune) plasma (CIP) treatment of COVID-19. This is performed explicitly to show the applicability of ANNs in forecasting the daily number of patients recovered from COVID-19. Second, the ANNs-based approach is further applied to the data from Italy to confirm its robustness in other geographical contexts. Finally, to evaluate its forecasting accuracy, the proposed Multi-Layer Perceptron (MLP) approach is compared with other traditional models, including Autoregressive Integrated Moving Average (ARIMA), Long Short-term Memory (LSTM), and Nonlinear Autoregressive Network with Exogenous Inputs (NARX). Compared to the ARIMA, LSTM, and NARX, the MLP-based model is found to perform better in forecasting the number of people recovered from COVID-19. Overall, the findings suggest that the proposed model is robust and can be widely applied in other parts of the world in forecasting the patients recovered from COVID-19.
Identifiants
pubmed: 34794082
pii: S0010-4825(21)00823-4
doi: 10.1016/j.compbiomed.2021.105029
pmc: PMC8590479
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105029Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.